BackCelldex Therapeutics Overview

Celldex Therapeutics Profit Margin

Profitability ratio analysis for CLDX.

Quarterly Profit Margin

-524566.67%
↓ 6676.97% YoY

As of Mar 2026

Annual Profit Margin (TTM)

-34596.22%
↓ 1362.18% YoY

Trailing 12 months ending Mar 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin